Bipolar drug study halted early – what we know

NCT ID NCT06423794

Terminated Disease control Sponsor: Biohaven Therapeutics Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at the long-term safety of a daily drug called BHV-7000 in people with bipolar I disorder. It involved 94 participants who had completed an earlier study. The trial was terminated early, so the full safety picture is not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BHV-7000 (a drug taken once daily)

What this could lead to

If successful, this could point toward a safe long-term treatment option for managing bipolar I disorder.

What could go wrong

The trial was terminated early, so we have limited data. It is also a phase 2 study, meaning it is still early and may not lead to a proven treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder bipolar I disorder Mania

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER

Contacts and locations

Show contact details

Locations

Advanced Research Center, Inc.

Anaheim, California, 92805, United States
Arch Clinical Trials

St Louis, Missouri, 63141, United States
Atlanta Center for Medical Research

Atlanta, Georgia, 30331, United States
CBH Health

Gaithersburg, Maryland, 20877, United States
CIT IE

Riverside, California, 92506, United States
CIT LA

Bellflower, California, 90706, United States
CenExel iResearch, LLC

Decatur, Georgia, 30030, United States
CenExel iResearch, LLC

Savannah, Georgia, 31405, United States
Cenexel - RCA

Hollywood, Florida, 33024, United States
Cenexel CNS

Garden Grove, California, 92845, United States
Cenexel CNS

Torrance, California, 90504, United States
Community Clinical Research, Inc.

Austin, Texas, 78754, United States
Floridian Neuroscience Institute

Miami Lakes, Florida, 33016, United States
Hassman Research Institute

Marlton, New Jersey, 08053, United States
InSite Clinical Research, LLC

DeSoto, Texas, 75115, United States
LCC Medical Research Inst

Miami, Florida, 33126, United States
Midwest Clinical Research Center

Dayton, Ohio, 45417, United States
NBCR

North Canton, Ohio, 44720, United States
NRC Research Institute

Orange, California, 92868, United States
Neuroscience Research Institute

West Palm Beach, Florida, 33407, United States
Pillar Clinical Research

Chicago, Illinois, 60641, United States
Pillar Clinical Research, LLC

Bentonville, Arkansas, 72712, United States
Pillar Clinical Research, LLC

Richardson, Texas, 75080, United States
Precise Clinical Research

Flowood, Mississippi, 39232, United States
ProScience Research Group

Culver City, California, 90230, United States
RBA

Staten Island, New York, 10329, United States
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site

Hollywood, Florida, 33021, United States
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site

Miami Lakes, Florida, 33016, United States
Synergy San Diego

Lemon Grove, California, 91945, United States
Uptown Research Institute

Chicago, Illinois, 60640, United States
WIRG

Little Rock, Arkansas, 72211, United States
WRN

Rogers, Arkansas, 72758, United States